Earnings Call · Q4 FY2021·2022-02-22

Q4 21EPS +22.03%·Rev n/aQ3 21EPS +6.43%·Rev n/aQ2 21EPS +9.73%·Rev n/aQ1 21EPS -28.68%·Rev n/a⚠ consensus missing

Esperion Therapeutics, Inc. ESPR

Ben Church — Head of Investor Relations and Corporate Communications

Sheldon Koenig — Chief Executive Officer

Rick Bartram — Chief Financial Officer

+3.7%1d on move date+2.8% vs SPY3d+2.5%5d−7.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ESPR calls or request research access.

More ESPR calls Browse calls Request research access